CXCL3 was still firmly expressed by tumor cells in both Calu-6 and SK-MES tumors from myeloablated and hrIL-27-treated mice (Figure 4C), while a faint IFNγ production was only detected in the latter. The gene discussed is CXCL3; the disease is neoplasm.